Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CILGAVIMAB\TIXAGEVIMAB for Covid-19 immunisation: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 12 adverse event reports in the FDA FAERS database where CILGAVIMAB\TIXAGEVIMAB was used for Covid-19 immunisation.

Most Reported Side Effects for CILGAVIMAB\TIXAGEVIMAB

Side Effect Reports % Deaths Hosp.
Covid-19 521 24.0% 103 365
Drug ineffective 123 5.7% 16 75
Product use issue 94 4.3% 26 42
Fatigue 86 4.0% 2 16
Headache 86 4.0% 4 16
Dyspnoea 84 3.9% 9 36
Pyrexia 81 3.7% 4 48
Nausea 68 3.1% 0 17
Dizziness 64 3.0% 1 18
Breakthrough covid-19 51 2.4% 6 34
Pneumonia 49 2.3% 8 34
Atrial fibrillation 48 2.2% 3 31
Death 48 2.2% 48 3
Cough 47 2.2% 2 13
Pruritus 46 2.1% 0 6

Other Indications for CILGAVIMAB\TIXAGEVIMAB

Covid-19 prophylaxis (1,105) Covid-19 (287) Covid-19 treatment (146) Immunodeficiency (76) Prophylaxis (57) Product used for unknown indication (30) Immunisation (23) Immunosuppression (15) Renal transplant (14) Chronic lymphocytic leukaemia (11)

Other Drugs Used for Covid-19 immunisation

TOZINAMERAN (4,585) COVID-19 VACCINE NOS (1,641) ELASOMERAN (1,258) AZD-1222 (1,166) CX-024414 (385) COVID-19 VACCINE (305) AD26.COV2.S (190) NIRMATRELVIR\RITONAVIR (108) RAXTOZINAMERAN (43) BRETOVAMERAN (39)

Related Pages

CILGAVIMAB\TIXAGEVIMAB Full Profile All Covid-19 immunisation Drugs CILGAVIMAB\TIXAGEVIMAB Demographics CILGAVIMAB\TIXAGEVIMAB Timeline